Navigation Links
Breathe Technologies Sleep System Receives FDA Clearance
Date:5/30/2013

IRVINE, Calif., May 30, 2013 /PRNewswire/ -- Breathe Technologies, Inc., a manufacturer of innovative medical devices for people with respiratory conditions today announced the Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its Sleep System (Continuous Positive Airway Pressure, or CPAP & Interface) in the US for treatment of Obstructive Sleep Apnea (OSA). The Breathe Sleep System utilizes miniaturized technologies coupled with user-centric design to provide a new therapeutic solution for patients with OSA.

"Reaching this milestone ahead of schedule is a testament to the expertise of our world-class  team," said Larry Mastrovich , CEO of Breathe Technologies. "Our approach to respiratory care is centered on improving patients' quality of life. Based on extensive research with patients and clinicians, we have designed a clinically effective system with unique features."

Breathe's Sleep System is easy to set-up and provides effective CPAP therapy with a comfortable, discrete interface and tubing. Additional advanced features include a redesigned humidification system, an interactive patient touch-screen interface, and a smart pressure ramp function. Breathe Technologies product portfolio will be further enhanced with the addition of the Breathe Sleep System. Breathe Technologies' award-winning Non-Invasive OPEN Ventilation (NIOV™) System is a one pound, wearable hospital to home miniaturized ventilation device that facilitates early ambulation in hospital settings and enables patient independence in the home for better quality of life. NIOV™ is currently in use by clinicians and patients across the country, including public and private hospitals, VA healthcare facilities, pulmonary rehab centers, and with patients at home. 

For more information on Breathe Technologies' products visit www.breathetechnologies.com or contact us at info@breathetechnologies.com.

About Breathe Technologies, Inc.

Breathe Technologies, Inc., located in Irvine, California, is a developer and manufacturer of innovative medical technologies for treating respiratory conditions. The company was founded with the goal of transforming the lives of people with respiratory insufficiency by producing innovative therapies that have the potential to dramatically improve quality of life. The Breathe Non-Invasive OPEN Ventilation (NIOV™) System, featuring the company's proprietary OPEN-airway platform, is FDA-cleared for use in both the institutional and homecare settings. The Company has received FDA clearance for its Sleep System to address unmet needs in sleep apnea. Breathe has taken an integrated approach focused on an improved user experience, supported by innovative design and best in class therapy. Investors include Kleiner Perkins Caufield & Byers, Delphi Ventures, Johnson & Johnson Development Corporation, Synergy Partners International, DAG Ventures and Morgan Creek . For more information, please visit www.breathetechnologies.com


'/>"/>
SOURCE Breathe Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immortum Breathes Life Into End of Life Care
2. Breathe Technologies Non-Invasive Open Ventilation (NIOV™) System Receives Medical Design Award
3. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
4. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
5. Global Markets and Technologies for Optical Coherence Tomography (OCT)
6. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
7. Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
8. Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
9. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
10. MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
11. Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):